Cepheid Q2 Revenues Rise 14 Percent; Shares Fall on Q3 Guidance | GenomeWeb

NEW YORK (GenomeWeb) – Cepheid said after the close of the market Thursday that its second quarter revenues grew 14 percent year over year.

The firm reported total revenues of $132.5 million for the quarter ended June 30, up from $116.5 million in the comparable quarter a year ago, and besting the average analyst estimate of $130.7 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.